Advanced search
Publication Cover
Journal of Chemotherapy Volume 27, 2015 - Issue 3
Submit an article Journal homepage
116
Views
14
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2

Su Bien ParkDepartment of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Korea
,
Ji Hae LeeDepartment of Biological SciencesUniversity of Ulsan, Korea
,
Won Wook JeongDepartment of Biological SciencesUniversity of Ulsan, Korea
,
Yo Hwan KimDepartment of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Korea
,
Hee Jeong ChaDepartment of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Korea
,
Yeonsoo JoeDepartment of Biological SciencesUniversity of Ulsan, Korea
,
Hun Taeg ChungDepartment of Biological SciencesUniversity of Ulsan, Korea
,
Wha Ja ChoBiomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Korea
,
Jeong Wan DoNational Fisheries Research and Development Institute, Busan, Korea
,
Byung Ju LeeDepartment of Biological SciencesUniversity of Ulsan, Korea
,
Jeong Woo ParkDepartment of Biological SciencesUniversity of Ulsan, KoreaCorrespondence[email protected]
&
Byung Kyun KoDepartment of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Korea
 show all
Pages 174-180 | Published online: 21 Jan 2015

References

  • Mantovani G, Maccio A, Massa E, Mulas C, Mudu MC, Massidda S, et al. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation. Int J Oncol. 2000;16:1227–33.
  • Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol. 2001;67:93–130.
  • Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–79.
  • Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941–53.
  • Kaufmann SH, Gores GJ. Apoptosis in cancer: cause and cure. Bioessays. 2000;22(11):1007–17.
  • Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49–63.
  • Gallo O, Boddi V, Calzolari A, Simonetti L, Trovati M, Bianchi S. bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy. Clin Cancer Res. 1996;2(2):261–7.
  • Sharma H, Sen S, Mathur M, Bahadur S, Singh N. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck. 2004;26(8):733–40.
  • Suzuki A, Matsuzawa A, Igushi T. Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene. 1996;13:31–7.
  • Miyashita T, Krajewski S, Krajewska M, Wand HG, Lin HK, Hoffman B, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799–805.
  • Schiavone N, Rosini P, Quattrone A, Donnini M, Lapucci A, Citti L, et al. A conserved AU-rich element in the 39 untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J. 2000;14:174–84.
  • Shyu AB, Wilkinson MF. The double lives of shuttling mRNA binding proteins. Cell. 2000;102:135–8.
  • Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998;281:1001–5.
  • Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE containing mRNAs. EMBO J. 1998;17:3448–60.
  • Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 1998;17:3461–70.
  • Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M, et al. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J. 2002;17:4709–18.
  • Lapucci A, Donnini M, Papucci L, Witort E, Tempestini A, Bevilacqua A, et al. AUF1 is a bcl-2 A+U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis. J Biol Chem. 2002;277:16139–46.
  • Kim JS, Lee JH, Jeong WW, Choi DH, Cha HJ, Kim DH, et al. Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells. Int J Cancer. 2008;122:672–80.
  • Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol. 1997;117:775–84.
  • Kim CW, Vo MT, Kim HK, Lee HH, Yoon NA, Lee BJ, et al. Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28. Nucleic Acids Res. 2012;40:3856–69.
  • Lee SK, Kim SB, Kim JS, Moon CH, Han MS, Lee BJ, et al. Butyrate Response Factor 1 (BRF1) enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines. Int J Cancer. 2005;117:32–40.
  • Donnini M, Lapucci A, Papucci L, Witort E, Tempestini A, Brewer G, et al. Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins. Biochem Biophys Res Commun. 2001;287:1063–9.
  • Donnini M, Lapucci A, Papucci L, Witort E, Jacquier A, Brewer G, et al. Identification of TINO: a new evolutionarily conserved BCL-2 AU-rich element RNA-binding protein. J Biol Chem. 2004;279:20154–66.
  • Kim CW, Kim HK, Vo MT, Lee HH, Kim HJ, Min YJ, et al. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3(UTR of cIAP2 mRNA. Biochem Biophys Res Commun. 2010;400(1):46–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.